Alliqua (ALQA) Prelim. Q2 Revenue Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Alliqua BioMedical, Inc. Announces Preliminary Second Quarter of Fiscal Year 2016 Revenue; Earnings Conference Call Scheduled for August 9th
July 7, 2016 7:20 AM EDTYARDLEY, Pa., July 07, 2016 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announced preliminary second quarter of fiscal year 2016 revenue results and timing and details of the second quarter financial results conference call.
Second Quarter Preliminary Revenue Estimate:
While the Company has not finalized its full financial results for the six month period ending June 30, 2016, it expects second quarter total revenue of approximately $5.4 million, representing growth... More
